Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report

The use of chimeric antigen receptor T cells (CAR-Ts) is effective in the treatment of hematological malignancies. It has been reported that HBV is reactivated after CAR-T immunotherapy for refractory/relapsed hematological malignant B-cell tumors. However, there is little literature on donor-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhihui, Meng, Fanqiao, Li, Jing, Wu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314645/
https://www.ncbi.nlm.nih.gov/pubmed/35903089
http://dx.doi.org/10.3389/fimmu.2022.931452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314645/
https://www.ncbi.nlm.nih.gov/pubmed/35903089
http://dx.doi.org/10.3389/fimmu.2022.931452

Ejemplares similares